Unauthorized pre-workout supplement "Dust Extreme" seized from Minotaure Nutrition in Quebec

Starting date:

May 2, 2017

Posting date:

May 2, 2017

Type of communication:

Advisory

Subcategory:

Natural health products

Source of recall:

Health Canada

Issue:

Unauthorized products

Audience:

General Public

Identification number:

RA-63182

• Issue
• Products affected
• What you should do
• Who is affected
• Background
• Media enquiries
• Public enquiries
• What Health Canada is doing
• Images

Issue

Health Canada is advising Canadians that it has seized the unauthorized health product “Dust Extreme” by Blackstone Labs, from Minotaure Nutrition, at 5333 Laurier Blvd., Unit 130, in Terrebonne, QC.

“Dust Extreme” is promoted as a pre-workout supplement and is labelled to contain the unauthorized drug 1,3 Dimethylamylamine (DMAA), which may pose serious risks to the health of Canadians.

Products affected

Dust Extreme – Saveur d’oursons en gélatine acidulés (« Sour Gummy Bear »), de Blackstone Labs

What you should do

• Stop using this product. Consult with your health care professional if you have used this product and have health concerns.
• Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada’s Drug Product Database and Licensed Natural Health Product Database.
• Report adverse events to health products to Health Canada by calling toll-free at 1 866 234 2345, or by reporting online, by mail or by fax.
• Report complaints about health products to Health Canada by calling toll-free at 1 800 267 9675, or complete an online complaint form.

Who is affected

Consumers who have bought or used this product

Background

1,3-Dimethylamylamine (DMAA) is a drug that is not authorized for use in Canada. Side effects include high blood pressure, shortness of breath, chest pain, stroke and psychiatric effects.

Media enquiries

Health Canada
(613) 957-2983

Public enquiries

(613) 957-2991
1-866 225-0709

What Health Canada is doing

Health Canada seized the product from the retail location. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary.

Images

Select thumbnail to enlarge - opens in a new window